Pharma & Healthcare
Global Tuberculosis Drugs Market Research Report 2025
- Sep 09, 25
- ID: 497006
- Pages: 99
- Figures: 105
- Views: 5
Report Scope
This report aims to provide a comprehensive presentation of the global market for Tuberculosis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis Drugs.
The Tuberculosis Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tuberculosis Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tuberculosis Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Pfizer Inc
Lupin Laboratories Ltd
AstraZeneca Plc
Cadila Pharmaceuticals
Novartis AG
Alkem Laboratories Ltd
Cipla Ltd
Otsuka Pharmaceutical
Sanofi
Abbott
ANI Pharmaceuticals, Inc
Teva Pharmaceutical Industries Ltd
Macleods Pharmaceuticals Ltd.
Johnson & Johnson
FRESENIUS SE & Co. KGaA (Fresenius Kabi)
Eli Lilly and Company
Viatris Inc. (Mylan N.V.)
Sun Pharmaceutical Industries Ltd.
Segment by Type
First Line Drugs Therapy
Second Line Drugs Therapy
Combination Drugs Therapy
Segment by Application
Hospital
Private Clinic
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tuberculosis Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tuberculosis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for Tuberculosis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis Drugs.
The Tuberculosis Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tuberculosis Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tuberculosis Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Pfizer Inc
Lupin Laboratories Ltd
AstraZeneca Plc
Cadila Pharmaceuticals
Novartis AG
Alkem Laboratories Ltd
Cipla Ltd
Otsuka Pharmaceutical
Sanofi
Abbott
ANI Pharmaceuticals, Inc
Teva Pharmaceutical Industries Ltd
Macleods Pharmaceuticals Ltd.
Johnson & Johnson
FRESENIUS SE & Co. KGaA (Fresenius Kabi)
Eli Lilly and Company
Viatris Inc. (Mylan N.V.)
Sun Pharmaceutical Industries Ltd.
Segment by Type
First Line Drugs Therapy
Second Line Drugs Therapy
Combination Drugs Therapy
Segment by Application
Hospital
Private Clinic
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tuberculosis Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tuberculosis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Tuberculosis Drugs Market Overview
1.1 Product Definition
1.2 Tuberculosis Drugs by Type
1.2.1 Global Tuberculosis Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 First Line Drugs Therapy
1.2.3 Second Line Drugs Therapy
1.2.4 Combination Drugs Therapy
1.3 Tuberculosis Drugs by Application
1.3.1 Global Tuberculosis Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Private Clinic
1.3.4 Others
1.4 Global Tuberculosis Drugs Market Size Estimates and Forecasts
1.4.1 Global Tuberculosis Drugs Revenue 2020-2031
1.4.2 Global Tuberculosis Drugs Sales 2020-2031
1.4.3 Global Tuberculosis Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Tuberculosis Drugs Market Competition by Manufacturers
2.1 Global Tuberculosis Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Tuberculosis Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Tuberculosis Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Tuberculosis Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tuberculosis Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tuberculosis Drugs, Product Type & Application
2.7 Global Key Manufacturers of Tuberculosis Drugs, Date of Enter into This Industry
2.8 Global Tuberculosis Drugs Market Competitive Situation and Trends
2.8.1 Global Tuberculosis Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Tuberculosis Drugs Players Market Share by Revenue
2.8.3 Global Tuberculosis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Tuberculosis Drugs Market Scenario by Region
3.1 Global Tuberculosis Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Tuberculosis Drugs Sales by Region: 2020-2031
3.2.1 Global Tuberculosis Drugs Sales by Region: 2020-2025
3.2.2 Global Tuberculosis Drugs Sales by Region: 2026-2031
3.3 Global Tuberculosis Drugs Revenue by Region: 2020-2031
3.3.1 Global Tuberculosis Drugs Revenue by Region: 2020-2025
3.3.2 Global Tuberculosis Drugs Revenue by Region: 2026-2031
3.4 North America Tuberculosis Drugs Market Facts & Figures by Country
3.4.1 North America Tuberculosis Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Tuberculosis Drugs Sales by Country (2020-2031)
3.4.3 North America Tuberculosis Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Tuberculosis Drugs Market Facts & Figures by Country
3.5.1 Europe Tuberculosis Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Tuberculosis Drugs Sales by Country (2020-2031)
3.5.3 Europe Tuberculosis Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tuberculosis Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Tuberculosis Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Tuberculosis Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Tuberculosis Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Tuberculosis Drugs Market Facts & Figures by Country
3.7.1 Latin America Tuberculosis Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Tuberculosis Drugs Sales by Country (2020-2031)
3.7.3 Latin America Tuberculosis Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tuberculosis Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Tuberculosis Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Tuberculosis Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Tuberculosis Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Tuberculosis Drugs Sales by Type (2020-2031)
4.1.1 Global Tuberculosis Drugs Sales by Type (2020-2025)
4.1.2 Global Tuberculosis Drugs Sales by Type (2026-2031)
4.1.3 Global Tuberculosis Drugs Sales Market Share by Type (2020-2031)
4.2 Global Tuberculosis Drugs Revenue by Type (2020-2031)
4.2.1 Global Tuberculosis Drugs Revenue by Type (2020-2025)
4.2.2 Global Tuberculosis Drugs Revenue by Type (2026-2031)
4.2.3 Global Tuberculosis Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Tuberculosis Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Tuberculosis Drugs Sales by Application (2020-2031)
5.1.1 Global Tuberculosis Drugs Sales by Application (2020-2025)
5.1.2 Global Tuberculosis Drugs Sales by Application (2026-2031)
5.1.3 Global Tuberculosis Drugs Sales Market Share by Application (2020-2031)
5.2 Global Tuberculosis Drugs Revenue by Application (2020-2031)
5.2.1 Global Tuberculosis Drugs Revenue by Application (2020-2025)
5.2.2 Global Tuberculosis Drugs Revenue by Application (2026-2031)
5.2.3 Global Tuberculosis Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Tuberculosis Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer Inc
6.1.1 Pfizer Inc Company Information
6.1.2 Pfizer Inc Description and Business Overview
6.1.3 Pfizer Inc Tuberculosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Inc Tuberculosis Drugs Product Portfolio
6.1.5 Pfizer Inc Recent Developments/Updates
6.2 Lupin Laboratories Ltd
6.2.1 Lupin Laboratories Ltd Company Information
6.2.2 Lupin Laboratories Ltd Description and Business Overview
6.2.3 Lupin Laboratories Ltd Tuberculosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Lupin Laboratories Ltd Tuberculosis Drugs Product Portfolio
6.2.5 Lupin Laboratories Ltd Recent Developments/Updates
6.3 AstraZeneca Plc
6.3.1 AstraZeneca Plc Company Information
6.3.2 AstraZeneca Plc Description and Business Overview
6.3.3 AstraZeneca Plc Tuberculosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 AstraZeneca Plc Tuberculosis Drugs Product Portfolio
6.3.5 AstraZeneca Plc Recent Developments/Updates
6.4 Cadila Pharmaceuticals
6.4.1 Cadila Pharmaceuticals Company Information
6.4.2 Cadila Pharmaceuticals Description and Business Overview
6.4.3 Cadila Pharmaceuticals Tuberculosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Cadila Pharmaceuticals Tuberculosis Drugs Product Portfolio
6.4.5 Cadila Pharmaceuticals Recent Developments/Updates
6.5 Novartis AG
6.5.1 Novartis AG Company Information
6.5.2 Novartis AG Description and Business Overview
6.5.3 Novartis AG Tuberculosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Novartis AG Tuberculosis Drugs Product Portfolio
6.5.5 Novartis AG Recent Developments/Updates
6.6 Alkem Laboratories Ltd
6.6.1 Alkem Laboratories Ltd Company Information
6.6.2 Alkem Laboratories Ltd Description and Business Overview
6.6.3 Alkem Laboratories Ltd Tuberculosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Alkem Laboratories Ltd Tuberculosis Drugs Product Portfolio
6.6.5 Alkem Laboratories Ltd Recent Developments/Updates
6.7 Cipla Ltd
6.7.1 Cipla Ltd Company Information
6.7.2 Cipla Ltd Description and Business Overview
6.7.3 Cipla Ltd Tuberculosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Cipla Ltd Tuberculosis Drugs Product Portfolio
6.7.5 Cipla Ltd Recent Developments/Updates
6.8 Otsuka Pharmaceutical
6.8.1 Otsuka Pharmaceutical Company Information
6.8.2 Otsuka Pharmaceutical Description and Business Overview
6.8.3 Otsuka Pharmaceutical Tuberculosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Otsuka Pharmaceutical Tuberculosis Drugs Product Portfolio
6.8.5 Otsuka Pharmaceutical Recent Developments/Updates
6.9 Sanofi
6.9.1 Sanofi Company Information
6.9.2 Sanofi Description and Business Overview
6.9.3 Sanofi Tuberculosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Sanofi Tuberculosis Drugs Product Portfolio
6.9.5 Sanofi Recent Developments/Updates
6.10 Abbott
6.10.1 Abbott Company Information
6.10.2 Abbott Description and Business Overview
6.10.3 Abbott Tuberculosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Abbott Tuberculosis Drugs Product Portfolio
6.10.5 Abbott Recent Developments/Updates
6.11 ANI Pharmaceuticals, Inc
6.11.1 ANI Pharmaceuticals, Inc Company Information
6.11.2 ANI Pharmaceuticals, Inc Description and Business Overview
6.11.3 ANI Pharmaceuticals, Inc Tuberculosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 ANI Pharmaceuticals, Inc Tuberculosis Drugs Product Portfolio
6.11.5 ANI Pharmaceuticals, Inc Recent Developments/Updates
6.12 Teva Pharmaceutical Industries Ltd
6.12.1 Teva Pharmaceutical Industries Ltd Company Information
6.12.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
6.12.3 Teva Pharmaceutical Industries Ltd Tuberculosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Teva Pharmaceutical Industries Ltd Tuberculosis Drugs Product Portfolio
6.12.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
6.13 Macleods Pharmaceuticals Ltd.
6.13.1 Macleods Pharmaceuticals Ltd. Company Information
6.13.2 Macleods Pharmaceuticals Ltd. Description and Business Overview
6.13.3 Macleods Pharmaceuticals Ltd. Tuberculosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Macleods Pharmaceuticals Ltd. Tuberculosis Drugs Product Portfolio
6.13.5 Macleods Pharmaceuticals Ltd. Recent Developments/Updates
6.14 Johnson & Johnson
6.14.1 Johnson & Johnson Company Information
6.14.2 Johnson & Johnson Description and Business Overview
6.14.3 Johnson & Johnson Tuberculosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Johnson & Johnson Tuberculosis Drugs Product Portfolio
6.14.5 Johnson & Johnson Recent Developments/Updates
6.15 FRESENIUS SE & Co. KGaA (Fresenius Kabi)
6.15.1 FRESENIUS SE & Co. KGaA (Fresenius Kabi) Company Information
6.15.2 FRESENIUS SE & Co. KGaA (Fresenius Kabi) Description and Business Overview
6.15.3 FRESENIUS SE & Co. KGaA (Fresenius Kabi) Tuberculosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 FRESENIUS SE & Co. KGaA (Fresenius Kabi) Tuberculosis Drugs Product Portfolio
6.15.5 FRESENIUS SE & Co. KGaA (Fresenius Kabi) Recent Developments/Updates
6.16 Eli Lilly and Company
6.16.1 Eli Lilly and Company Company Information
6.16.2 Eli Lilly and Company Description and Business Overview
6.16.3 Eli Lilly and Company Tuberculosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Eli Lilly and Company Tuberculosis Drugs Product Portfolio
6.16.5 Eli Lilly and Company Recent Developments/Updates
6.17 Viatris Inc. (Mylan N.V.)
6.17.1 Viatris Inc. (Mylan N.V.) Company Information
6.17.2 Viatris Inc. (Mylan N.V.) Description and Business Overview
6.17.3 Viatris Inc. (Mylan N.V.) Tuberculosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Viatris Inc. (Mylan N.V.) Tuberculosis Drugs Product Portfolio
6.17.5 Viatris Inc. (Mylan N.V.) Recent Developments/Updates
6.18 Sun Pharmaceutical Industries Ltd.
6.18.1 Sun Pharmaceutical Industries Ltd. Company Information
6.18.2 Sun Pharmaceutical Industries Ltd. Description and Business Overview
6.18.3 Sun Pharmaceutical Industries Ltd. Tuberculosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Sun Pharmaceutical Industries Ltd. Tuberculosis Drugs Product Portfolio
6.18.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tuberculosis Drugs Industry Chain Analysis
7.2 Tuberculosis Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tuberculosis Drugs Production Mode & Process Analysis
7.4 Tuberculosis Drugs Sales and Marketing
7.4.1 Tuberculosis Drugs Sales Channels
7.4.2 Tuberculosis Drugs Distributors
7.5 Tuberculosis Drugs Customer Analysis
8 Tuberculosis Drugs Market Dynamics
8.1 Tuberculosis Drugs Industry Trends
8.2 Tuberculosis Drugs Market Drivers
8.3 Tuberculosis Drugs Market Challenges
8.4 Tuberculosis Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Tuberculosis Drugs by Type
1.2.1 Global Tuberculosis Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 First Line Drugs Therapy
1.2.3 Second Line Drugs Therapy
1.2.4 Combination Drugs Therapy
1.3 Tuberculosis Drugs by Application
1.3.1 Global Tuberculosis Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Private Clinic
1.3.4 Others
1.4 Global Tuberculosis Drugs Market Size Estimates and Forecasts
1.4.1 Global Tuberculosis Drugs Revenue 2020-2031
1.4.2 Global Tuberculosis Drugs Sales 2020-2031
1.4.3 Global Tuberculosis Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Tuberculosis Drugs Market Competition by Manufacturers
2.1 Global Tuberculosis Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Tuberculosis Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Tuberculosis Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Tuberculosis Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tuberculosis Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tuberculosis Drugs, Product Type & Application
2.7 Global Key Manufacturers of Tuberculosis Drugs, Date of Enter into This Industry
2.8 Global Tuberculosis Drugs Market Competitive Situation and Trends
2.8.1 Global Tuberculosis Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Tuberculosis Drugs Players Market Share by Revenue
2.8.3 Global Tuberculosis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Tuberculosis Drugs Market Scenario by Region
3.1 Global Tuberculosis Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Tuberculosis Drugs Sales by Region: 2020-2031
3.2.1 Global Tuberculosis Drugs Sales by Region: 2020-2025
3.2.2 Global Tuberculosis Drugs Sales by Region: 2026-2031
3.3 Global Tuberculosis Drugs Revenue by Region: 2020-2031
3.3.1 Global Tuberculosis Drugs Revenue by Region: 2020-2025
3.3.2 Global Tuberculosis Drugs Revenue by Region: 2026-2031
3.4 North America Tuberculosis Drugs Market Facts & Figures by Country
3.4.1 North America Tuberculosis Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Tuberculosis Drugs Sales by Country (2020-2031)
3.4.3 North America Tuberculosis Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Tuberculosis Drugs Market Facts & Figures by Country
3.5.1 Europe Tuberculosis Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Tuberculosis Drugs Sales by Country (2020-2031)
3.5.3 Europe Tuberculosis Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tuberculosis Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Tuberculosis Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Tuberculosis Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Tuberculosis Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Tuberculosis Drugs Market Facts & Figures by Country
3.7.1 Latin America Tuberculosis Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Tuberculosis Drugs Sales by Country (2020-2031)
3.7.3 Latin America Tuberculosis Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tuberculosis Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Tuberculosis Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Tuberculosis Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Tuberculosis Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Tuberculosis Drugs Sales by Type (2020-2031)
4.1.1 Global Tuberculosis Drugs Sales by Type (2020-2025)
4.1.2 Global Tuberculosis Drugs Sales by Type (2026-2031)
4.1.3 Global Tuberculosis Drugs Sales Market Share by Type (2020-2031)
4.2 Global Tuberculosis Drugs Revenue by Type (2020-2031)
4.2.1 Global Tuberculosis Drugs Revenue by Type (2020-2025)
4.2.2 Global Tuberculosis Drugs Revenue by Type (2026-2031)
4.2.3 Global Tuberculosis Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Tuberculosis Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Tuberculosis Drugs Sales by Application (2020-2031)
5.1.1 Global Tuberculosis Drugs Sales by Application (2020-2025)
5.1.2 Global Tuberculosis Drugs Sales by Application (2026-2031)
5.1.3 Global Tuberculosis Drugs Sales Market Share by Application (2020-2031)
5.2 Global Tuberculosis Drugs Revenue by Application (2020-2031)
5.2.1 Global Tuberculosis Drugs Revenue by Application (2020-2025)
5.2.2 Global Tuberculosis Drugs Revenue by Application (2026-2031)
5.2.3 Global Tuberculosis Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Tuberculosis Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer Inc
6.1.1 Pfizer Inc Company Information
6.1.2 Pfizer Inc Description and Business Overview
6.1.3 Pfizer Inc Tuberculosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Inc Tuberculosis Drugs Product Portfolio
6.1.5 Pfizer Inc Recent Developments/Updates
6.2 Lupin Laboratories Ltd
6.2.1 Lupin Laboratories Ltd Company Information
6.2.2 Lupin Laboratories Ltd Description and Business Overview
6.2.3 Lupin Laboratories Ltd Tuberculosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Lupin Laboratories Ltd Tuberculosis Drugs Product Portfolio
6.2.5 Lupin Laboratories Ltd Recent Developments/Updates
6.3 AstraZeneca Plc
6.3.1 AstraZeneca Plc Company Information
6.3.2 AstraZeneca Plc Description and Business Overview
6.3.3 AstraZeneca Plc Tuberculosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 AstraZeneca Plc Tuberculosis Drugs Product Portfolio
6.3.5 AstraZeneca Plc Recent Developments/Updates
6.4 Cadila Pharmaceuticals
6.4.1 Cadila Pharmaceuticals Company Information
6.4.2 Cadila Pharmaceuticals Description and Business Overview
6.4.3 Cadila Pharmaceuticals Tuberculosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Cadila Pharmaceuticals Tuberculosis Drugs Product Portfolio
6.4.5 Cadila Pharmaceuticals Recent Developments/Updates
6.5 Novartis AG
6.5.1 Novartis AG Company Information
6.5.2 Novartis AG Description and Business Overview
6.5.3 Novartis AG Tuberculosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Novartis AG Tuberculosis Drugs Product Portfolio
6.5.5 Novartis AG Recent Developments/Updates
6.6 Alkem Laboratories Ltd
6.6.1 Alkem Laboratories Ltd Company Information
6.6.2 Alkem Laboratories Ltd Description and Business Overview
6.6.3 Alkem Laboratories Ltd Tuberculosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Alkem Laboratories Ltd Tuberculosis Drugs Product Portfolio
6.6.5 Alkem Laboratories Ltd Recent Developments/Updates
6.7 Cipla Ltd
6.7.1 Cipla Ltd Company Information
6.7.2 Cipla Ltd Description and Business Overview
6.7.3 Cipla Ltd Tuberculosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Cipla Ltd Tuberculosis Drugs Product Portfolio
6.7.5 Cipla Ltd Recent Developments/Updates
6.8 Otsuka Pharmaceutical
6.8.1 Otsuka Pharmaceutical Company Information
6.8.2 Otsuka Pharmaceutical Description and Business Overview
6.8.3 Otsuka Pharmaceutical Tuberculosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Otsuka Pharmaceutical Tuberculosis Drugs Product Portfolio
6.8.5 Otsuka Pharmaceutical Recent Developments/Updates
6.9 Sanofi
6.9.1 Sanofi Company Information
6.9.2 Sanofi Description and Business Overview
6.9.3 Sanofi Tuberculosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Sanofi Tuberculosis Drugs Product Portfolio
6.9.5 Sanofi Recent Developments/Updates
6.10 Abbott
6.10.1 Abbott Company Information
6.10.2 Abbott Description and Business Overview
6.10.3 Abbott Tuberculosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Abbott Tuberculosis Drugs Product Portfolio
6.10.5 Abbott Recent Developments/Updates
6.11 ANI Pharmaceuticals, Inc
6.11.1 ANI Pharmaceuticals, Inc Company Information
6.11.2 ANI Pharmaceuticals, Inc Description and Business Overview
6.11.3 ANI Pharmaceuticals, Inc Tuberculosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 ANI Pharmaceuticals, Inc Tuberculosis Drugs Product Portfolio
6.11.5 ANI Pharmaceuticals, Inc Recent Developments/Updates
6.12 Teva Pharmaceutical Industries Ltd
6.12.1 Teva Pharmaceutical Industries Ltd Company Information
6.12.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
6.12.3 Teva Pharmaceutical Industries Ltd Tuberculosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Teva Pharmaceutical Industries Ltd Tuberculosis Drugs Product Portfolio
6.12.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
6.13 Macleods Pharmaceuticals Ltd.
6.13.1 Macleods Pharmaceuticals Ltd. Company Information
6.13.2 Macleods Pharmaceuticals Ltd. Description and Business Overview
6.13.3 Macleods Pharmaceuticals Ltd. Tuberculosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Macleods Pharmaceuticals Ltd. Tuberculosis Drugs Product Portfolio
6.13.5 Macleods Pharmaceuticals Ltd. Recent Developments/Updates
6.14 Johnson & Johnson
6.14.1 Johnson & Johnson Company Information
6.14.2 Johnson & Johnson Description and Business Overview
6.14.3 Johnson & Johnson Tuberculosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Johnson & Johnson Tuberculosis Drugs Product Portfolio
6.14.5 Johnson & Johnson Recent Developments/Updates
6.15 FRESENIUS SE & Co. KGaA (Fresenius Kabi)
6.15.1 FRESENIUS SE & Co. KGaA (Fresenius Kabi) Company Information
6.15.2 FRESENIUS SE & Co. KGaA (Fresenius Kabi) Description and Business Overview
6.15.3 FRESENIUS SE & Co. KGaA (Fresenius Kabi) Tuberculosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 FRESENIUS SE & Co. KGaA (Fresenius Kabi) Tuberculosis Drugs Product Portfolio
6.15.5 FRESENIUS SE & Co. KGaA (Fresenius Kabi) Recent Developments/Updates
6.16 Eli Lilly and Company
6.16.1 Eli Lilly and Company Company Information
6.16.2 Eli Lilly and Company Description and Business Overview
6.16.3 Eli Lilly and Company Tuberculosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Eli Lilly and Company Tuberculosis Drugs Product Portfolio
6.16.5 Eli Lilly and Company Recent Developments/Updates
6.17 Viatris Inc. (Mylan N.V.)
6.17.1 Viatris Inc. (Mylan N.V.) Company Information
6.17.2 Viatris Inc. (Mylan N.V.) Description and Business Overview
6.17.3 Viatris Inc. (Mylan N.V.) Tuberculosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Viatris Inc. (Mylan N.V.) Tuberculosis Drugs Product Portfolio
6.17.5 Viatris Inc. (Mylan N.V.) Recent Developments/Updates
6.18 Sun Pharmaceutical Industries Ltd.
6.18.1 Sun Pharmaceutical Industries Ltd. Company Information
6.18.2 Sun Pharmaceutical Industries Ltd. Description and Business Overview
6.18.3 Sun Pharmaceutical Industries Ltd. Tuberculosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Sun Pharmaceutical Industries Ltd. Tuberculosis Drugs Product Portfolio
6.18.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tuberculosis Drugs Industry Chain Analysis
7.2 Tuberculosis Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tuberculosis Drugs Production Mode & Process Analysis
7.4 Tuberculosis Drugs Sales and Marketing
7.4.1 Tuberculosis Drugs Sales Channels
7.4.2 Tuberculosis Drugs Distributors
7.5 Tuberculosis Drugs Customer Analysis
8 Tuberculosis Drugs Market Dynamics
8.1 Tuberculosis Drugs Industry Trends
8.2 Tuberculosis Drugs Market Drivers
8.3 Tuberculosis Drugs Market Challenges
8.4 Tuberculosis Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Tuberculosis Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Tuberculosis Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Tuberculosis Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Tuberculosis Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Tuberculosis Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Tuberculosis Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Tuberculosis Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Tuberculosis Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Tuberculosis Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Tuberculosis Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Tuberculosis Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Tuberculosis Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Tuberculosis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Tuberculosis Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Tuberculosis Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Tuberculosis Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Tuberculosis Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Tuberculosis Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Tuberculosis Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Tuberculosis Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Tuberculosis Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Tuberculosis Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Tuberculosis Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Tuberculosis Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Tuberculosis Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Tuberculosis Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Tuberculosis Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Tuberculosis Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Tuberculosis Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Tuberculosis Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Tuberculosis Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Tuberculosis Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Tuberculosis Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Tuberculosis Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Tuberculosis Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Tuberculosis Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Tuberculosis Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Tuberculosis Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Tuberculosis Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Tuberculosis Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Tuberculosis Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Tuberculosis Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Tuberculosis Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Tuberculosis Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Tuberculosis Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Tuberculosis Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Tuberculosis Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Tuberculosis Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Tuberculosis Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Tuberculosis Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Tuberculosis Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Tuberculosis Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Tuberculosis Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Tuberculosis Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Tuberculosis Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Tuberculosis Drugs Price (USD/Unit) by Type (2020-2025)
Table 59. Global Tuberculosis Drugs Price (USD/Unit) by Type (2026-2031)
Table 60. Global Tuberculosis Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Tuberculosis Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Tuberculosis Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Tuberculosis Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Tuberculosis Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Tuberculosis Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Tuberculosis Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Tuberculosis Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Tuberculosis Drugs Price (USD/Unit) by Application (2020-2025)
Table 69. Global Tuberculosis Drugs Price (USD/Unit) by Application (2026-2031)
Table 70. Pfizer Inc Company Information
Table 71. Pfizer Inc Description and Business Overview
Table 72. Pfizer Inc Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Pfizer Inc Tuberculosis Drugs Product
Table 74. Pfizer Inc Recent Developments/Updates
Table 75. Lupin Laboratories Ltd Company Information
Table 76. Lupin Laboratories Ltd Description and Business Overview
Table 77. Lupin Laboratories Ltd Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Lupin Laboratories Ltd Tuberculosis Drugs Product
Table 79. Lupin Laboratories Ltd Recent Developments/Updates
Table 80. AstraZeneca Plc Company Information
Table 81. AstraZeneca Plc Description and Business Overview
Table 82. AstraZeneca Plc Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. AstraZeneca Plc Tuberculosis Drugs Product
Table 84. AstraZeneca Plc Recent Developments/Updates
Table 85. Cadila Pharmaceuticals Company Information
Table 86. Cadila Pharmaceuticals Description and Business Overview
Table 87. Cadila Pharmaceuticals Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Cadila Pharmaceuticals Tuberculosis Drugs Product
Table 89. Cadila Pharmaceuticals Recent Developments/Updates
Table 90. Novartis AG Company Information
Table 91. Novartis AG Description and Business Overview
Table 92. Novartis AG Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Novartis AG Tuberculosis Drugs Product
Table 94. Novartis AG Recent Developments/Updates
Table 95. Alkem Laboratories Ltd Company Information
Table 96. Alkem Laboratories Ltd Description and Business Overview
Table 97. Alkem Laboratories Ltd Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Alkem Laboratories Ltd Tuberculosis Drugs Product
Table 99. Alkem Laboratories Ltd Recent Developments/Updates
Table 100. Cipla Ltd Company Information
Table 101. Cipla Ltd Description and Business Overview
Table 102. Cipla Ltd Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Cipla Ltd Tuberculosis Drugs Product
Table 104. Cipla Ltd Recent Developments/Updates
Table 105. Otsuka Pharmaceutical Company Information
Table 106. Otsuka Pharmaceutical Description and Business Overview
Table 107. Otsuka Pharmaceutical Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Otsuka Pharmaceutical Tuberculosis Drugs Product
Table 109. Otsuka Pharmaceutical Recent Developments/Updates
Table 110. Sanofi Company Information
Table 111. Sanofi Description and Business Overview
Table 112. Sanofi Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Sanofi Tuberculosis Drugs Product
Table 114. Sanofi Recent Developments/Updates
Table 115. Abbott Company Information
Table 116. Abbott Description and Business Overview
Table 117. Abbott Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Abbott Tuberculosis Drugs Product
Table 119. Abbott Recent Developments/Updates
Table 120. ANI Pharmaceuticals, Inc Company Information
Table 121. ANI Pharmaceuticals, Inc Description and Business Overview
Table 122. ANI Pharmaceuticals, Inc Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. ANI Pharmaceuticals, Inc Tuberculosis Drugs Product
Table 124. ANI Pharmaceuticals, Inc Recent Developments/Updates
Table 125. Teva Pharmaceutical Industries Ltd Company Information
Table 126. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 127. Teva Pharmaceutical Industries Ltd Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Teva Pharmaceutical Industries Ltd Tuberculosis Drugs Product
Table 129. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 130. Macleods Pharmaceuticals Ltd. Company Information
Table 131. Macleods Pharmaceuticals Ltd. Description and Business Overview
Table 132. Macleods Pharmaceuticals Ltd. Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Macleods Pharmaceuticals Ltd. Tuberculosis Drugs Product
Table 134. Macleods Pharmaceuticals Ltd. Recent Developments/Updates
Table 135. Johnson & Johnson Company Information
Table 136. Johnson & Johnson Description and Business Overview
Table 137. Johnson & Johnson Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Johnson & Johnson Tuberculosis Drugs Product
Table 139. Johnson & Johnson Recent Developments/Updates
Table 140. FRESENIUS SE & Co. KGaA (Fresenius Kabi) Company Information
Table 141. FRESENIUS SE & Co. KGaA (Fresenius Kabi) Description and Business Overview
Table 142. FRESENIUS SE & Co. KGaA (Fresenius Kabi) Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. FRESENIUS SE & Co. KGaA (Fresenius Kabi) Tuberculosis Drugs Product
Table 144. FRESENIUS SE & Co. KGaA (Fresenius Kabi) Recent Developments/Updates
Table 145. Eli Lilly and Company Company Information
Table 146. Eli Lilly and Company Description and Business Overview
Table 147. Eli Lilly and Company Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Eli Lilly and Company Tuberculosis Drugs Product
Table 149. Eli Lilly and Company Recent Developments/Updates
Table 150. Viatris Inc. (Mylan N.V.) Company Information
Table 151. Viatris Inc. (Mylan N.V.) Description and Business Overview
Table 152. Viatris Inc. (Mylan N.V.) Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Viatris Inc. (Mylan N.V.) Tuberculosis Drugs Product
Table 154. Viatris Inc. (Mylan N.V.) Recent Developments/Updates
Table 155. Sun Pharmaceutical Industries Ltd. Company Information
Table 156. Sun Pharmaceutical Industries Ltd. Description and Business Overview
Table 157. Sun Pharmaceutical Industries Ltd. Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. Sun Pharmaceutical Industries Ltd. Tuberculosis Drugs Product
Table 159. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Tuberculosis Drugs Distributors List
Table 163. Tuberculosis Drugs Customers List
Table 164. Tuberculosis Drugs Market Trends
Table 165. Tuberculosis Drugs Market Drivers
Table 166. Tuberculosis Drugs Market Challenges
Table 167. Tuberculosis Drugs Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
Table 171. Authors List of This Report
List of Figures
Figure 1. Product Picture of Tuberculosis Drugs
Figure 2. Global Tuberculosis Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Tuberculosis Drugs Market Share by Type: 2024 & 2031
Figure 4. First Line Drugs Therapy Product Picture
Figure 5. Second Line Drugs Therapy Product Picture
Figure 6. Combination Drugs Therapy Product Picture
Figure 7. Global Tuberculosis Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Tuberculosis Drugs Market Share by Application: 2024 & 2031
Figure 9. Hospital
Figure 10. Private Clinic
Figure 11. Others
Figure 12. Global Tuberculosis Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Tuberculosis Drugs Market Size (2020-2031) & (US$ Million)
Figure 14. Global Tuberculosis Drugs Sales (2020-2031) & (K Units)
Figure 15. Global Tuberculosis Drugs Average Price (USD/Unit) & (2020-2031)
Figure 16. Tuberculosis Drugs Report Years Considered
Figure 17. Tuberculosis Drugs Sales Share by Manufacturers in 2024
Figure 18. Global Tuberculosis Drugs Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Tuberculosis Drugs Players: Market Share by Revenue in Tuberculosis Drugs in 2024
Figure 20. Tuberculosis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Tuberculosis Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Tuberculosis Drugs Sales Market Share by Country (2020-2031)
Figure 23. North America Tuberculosis Drugs Revenue Market Share by Country (2020-2031)
Figure 24. U.S. Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Tuberculosis Drugs Sales Market Share by Country (2020-2031)
Figure 27. Europe Tuberculosis Drugs Revenue Market Share by Country (2020-2031)
Figure 28. Germany Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Tuberculosis Drugs Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Tuberculosis Drugs Revenue Market Share by Region (2020-2031)
Figure 35. China Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Taiwan Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Philippines Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Tuberculosis Drugs Sales Market Share by Country (2020-2031)
Figure 46. Latin America Tuberculosis Drugs Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Tuberculosis Drugs Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Tuberculosis Drugs Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. U.A.E Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Tuberculosis Drugs by Type (2020-2031)
Figure 56. Global Revenue Market Share of Tuberculosis Drugs by Type (2020-2031)
Figure 57. Global Tuberculosis Drugs Price (USD/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Tuberculosis Drugs by Application (2020-2031)
Figure 59. Global Revenue Market Share of Tuberculosis Drugs by Application (2020-2031)
Figure 60. Global Tuberculosis Drugs Price (USD/Unit) by Application (2020-2031)
Figure 61. Tuberculosis Drugs Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Tuberculosis Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Tuberculosis Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Tuberculosis Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Tuberculosis Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Tuberculosis Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Tuberculosis Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Tuberculosis Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Tuberculosis Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Tuberculosis Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Tuberculosis Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Tuberculosis Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Tuberculosis Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Tuberculosis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Tuberculosis Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Tuberculosis Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Tuberculosis Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Tuberculosis Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Tuberculosis Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Tuberculosis Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Tuberculosis Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Tuberculosis Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Tuberculosis Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Tuberculosis Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Tuberculosis Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Tuberculosis Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Tuberculosis Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Tuberculosis Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Tuberculosis Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Tuberculosis Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Tuberculosis Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Tuberculosis Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Tuberculosis Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Tuberculosis Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Tuberculosis Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Tuberculosis Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Tuberculosis Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Tuberculosis Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Tuberculosis Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Tuberculosis Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Tuberculosis Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Tuberculosis Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Tuberculosis Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Tuberculosis Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Tuberculosis Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Tuberculosis Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Tuberculosis Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Tuberculosis Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Tuberculosis Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Tuberculosis Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Tuberculosis Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Tuberculosis Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Tuberculosis Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Tuberculosis Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Tuberculosis Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Tuberculosis Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Tuberculosis Drugs Price (USD/Unit) by Type (2020-2025)
Table 59. Global Tuberculosis Drugs Price (USD/Unit) by Type (2026-2031)
Table 60. Global Tuberculosis Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Tuberculosis Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Tuberculosis Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Tuberculosis Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Tuberculosis Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Tuberculosis Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Tuberculosis Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Tuberculosis Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Tuberculosis Drugs Price (USD/Unit) by Application (2020-2025)
Table 69. Global Tuberculosis Drugs Price (USD/Unit) by Application (2026-2031)
Table 70. Pfizer Inc Company Information
Table 71. Pfizer Inc Description and Business Overview
Table 72. Pfizer Inc Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Pfizer Inc Tuberculosis Drugs Product
Table 74. Pfizer Inc Recent Developments/Updates
Table 75. Lupin Laboratories Ltd Company Information
Table 76. Lupin Laboratories Ltd Description and Business Overview
Table 77. Lupin Laboratories Ltd Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Lupin Laboratories Ltd Tuberculosis Drugs Product
Table 79. Lupin Laboratories Ltd Recent Developments/Updates
Table 80. AstraZeneca Plc Company Information
Table 81. AstraZeneca Plc Description and Business Overview
Table 82. AstraZeneca Plc Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. AstraZeneca Plc Tuberculosis Drugs Product
Table 84. AstraZeneca Plc Recent Developments/Updates
Table 85. Cadila Pharmaceuticals Company Information
Table 86. Cadila Pharmaceuticals Description and Business Overview
Table 87. Cadila Pharmaceuticals Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Cadila Pharmaceuticals Tuberculosis Drugs Product
Table 89. Cadila Pharmaceuticals Recent Developments/Updates
Table 90. Novartis AG Company Information
Table 91. Novartis AG Description and Business Overview
Table 92. Novartis AG Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Novartis AG Tuberculosis Drugs Product
Table 94. Novartis AG Recent Developments/Updates
Table 95. Alkem Laboratories Ltd Company Information
Table 96. Alkem Laboratories Ltd Description and Business Overview
Table 97. Alkem Laboratories Ltd Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Alkem Laboratories Ltd Tuberculosis Drugs Product
Table 99. Alkem Laboratories Ltd Recent Developments/Updates
Table 100. Cipla Ltd Company Information
Table 101. Cipla Ltd Description and Business Overview
Table 102. Cipla Ltd Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Cipla Ltd Tuberculosis Drugs Product
Table 104. Cipla Ltd Recent Developments/Updates
Table 105. Otsuka Pharmaceutical Company Information
Table 106. Otsuka Pharmaceutical Description and Business Overview
Table 107. Otsuka Pharmaceutical Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Otsuka Pharmaceutical Tuberculosis Drugs Product
Table 109. Otsuka Pharmaceutical Recent Developments/Updates
Table 110. Sanofi Company Information
Table 111. Sanofi Description and Business Overview
Table 112. Sanofi Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Sanofi Tuberculosis Drugs Product
Table 114. Sanofi Recent Developments/Updates
Table 115. Abbott Company Information
Table 116. Abbott Description and Business Overview
Table 117. Abbott Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Abbott Tuberculosis Drugs Product
Table 119. Abbott Recent Developments/Updates
Table 120. ANI Pharmaceuticals, Inc Company Information
Table 121. ANI Pharmaceuticals, Inc Description and Business Overview
Table 122. ANI Pharmaceuticals, Inc Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. ANI Pharmaceuticals, Inc Tuberculosis Drugs Product
Table 124. ANI Pharmaceuticals, Inc Recent Developments/Updates
Table 125. Teva Pharmaceutical Industries Ltd Company Information
Table 126. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 127. Teva Pharmaceutical Industries Ltd Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Teva Pharmaceutical Industries Ltd Tuberculosis Drugs Product
Table 129. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 130. Macleods Pharmaceuticals Ltd. Company Information
Table 131. Macleods Pharmaceuticals Ltd. Description and Business Overview
Table 132. Macleods Pharmaceuticals Ltd. Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Macleods Pharmaceuticals Ltd. Tuberculosis Drugs Product
Table 134. Macleods Pharmaceuticals Ltd. Recent Developments/Updates
Table 135. Johnson & Johnson Company Information
Table 136. Johnson & Johnson Description and Business Overview
Table 137. Johnson & Johnson Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Johnson & Johnson Tuberculosis Drugs Product
Table 139. Johnson & Johnson Recent Developments/Updates
Table 140. FRESENIUS SE & Co. KGaA (Fresenius Kabi) Company Information
Table 141. FRESENIUS SE & Co. KGaA (Fresenius Kabi) Description and Business Overview
Table 142. FRESENIUS SE & Co. KGaA (Fresenius Kabi) Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. FRESENIUS SE & Co. KGaA (Fresenius Kabi) Tuberculosis Drugs Product
Table 144. FRESENIUS SE & Co. KGaA (Fresenius Kabi) Recent Developments/Updates
Table 145. Eli Lilly and Company Company Information
Table 146. Eli Lilly and Company Description and Business Overview
Table 147. Eli Lilly and Company Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Eli Lilly and Company Tuberculosis Drugs Product
Table 149. Eli Lilly and Company Recent Developments/Updates
Table 150. Viatris Inc. (Mylan N.V.) Company Information
Table 151. Viatris Inc. (Mylan N.V.) Description and Business Overview
Table 152. Viatris Inc. (Mylan N.V.) Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Viatris Inc. (Mylan N.V.) Tuberculosis Drugs Product
Table 154. Viatris Inc. (Mylan N.V.) Recent Developments/Updates
Table 155. Sun Pharmaceutical Industries Ltd. Company Information
Table 156. Sun Pharmaceutical Industries Ltd. Description and Business Overview
Table 157. Sun Pharmaceutical Industries Ltd. Tuberculosis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. Sun Pharmaceutical Industries Ltd. Tuberculosis Drugs Product
Table 159. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Tuberculosis Drugs Distributors List
Table 163. Tuberculosis Drugs Customers List
Table 164. Tuberculosis Drugs Market Trends
Table 165. Tuberculosis Drugs Market Drivers
Table 166. Tuberculosis Drugs Market Challenges
Table 167. Tuberculosis Drugs Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
Table 171. Authors List of This Report
List of Figures
Figure 1. Product Picture of Tuberculosis Drugs
Figure 2. Global Tuberculosis Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Tuberculosis Drugs Market Share by Type: 2024 & 2031
Figure 4. First Line Drugs Therapy Product Picture
Figure 5. Second Line Drugs Therapy Product Picture
Figure 6. Combination Drugs Therapy Product Picture
Figure 7. Global Tuberculosis Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Tuberculosis Drugs Market Share by Application: 2024 & 2031
Figure 9. Hospital
Figure 10. Private Clinic
Figure 11. Others
Figure 12. Global Tuberculosis Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Tuberculosis Drugs Market Size (2020-2031) & (US$ Million)
Figure 14. Global Tuberculosis Drugs Sales (2020-2031) & (K Units)
Figure 15. Global Tuberculosis Drugs Average Price (USD/Unit) & (2020-2031)
Figure 16. Tuberculosis Drugs Report Years Considered
Figure 17. Tuberculosis Drugs Sales Share by Manufacturers in 2024
Figure 18. Global Tuberculosis Drugs Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Tuberculosis Drugs Players: Market Share by Revenue in Tuberculosis Drugs in 2024
Figure 20. Tuberculosis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Tuberculosis Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Tuberculosis Drugs Sales Market Share by Country (2020-2031)
Figure 23. North America Tuberculosis Drugs Revenue Market Share by Country (2020-2031)
Figure 24. U.S. Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Tuberculosis Drugs Sales Market Share by Country (2020-2031)
Figure 27. Europe Tuberculosis Drugs Revenue Market Share by Country (2020-2031)
Figure 28. Germany Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Tuberculosis Drugs Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Tuberculosis Drugs Revenue Market Share by Region (2020-2031)
Figure 35. China Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Taiwan Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Philippines Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Tuberculosis Drugs Sales Market Share by Country (2020-2031)
Figure 46. Latin America Tuberculosis Drugs Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Tuberculosis Drugs Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Tuberculosis Drugs Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. U.A.E Tuberculosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Tuberculosis Drugs by Type (2020-2031)
Figure 56. Global Revenue Market Share of Tuberculosis Drugs by Type (2020-2031)
Figure 57. Global Tuberculosis Drugs Price (USD/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Tuberculosis Drugs by Application (2020-2031)
Figure 59. Global Revenue Market Share of Tuberculosis Drugs by Application (2020-2031)
Figure 60. Global Tuberculosis Drugs Price (USD/Unit) by Application (2020-2031)
Figure 61. Tuberculosis Drugs Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Outdoor Shed Market Research Report 2025
Sep 09, 25
Global Residential Outdoor Cabinet Market Research Report 2025
Sep 09, 25
Global Outdoor Storage Cabinet Market Research Report 2025
Sep 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232